IEX •
Healthcare •
Biotechnology •
Quote as of 06/24/2026 15:59
Company Profile
IndustryBiotechnology
SectorHealthcare
ExchangeIEX
Market Capitalization46.18 mln
Float8.57 mln
Earnings Date08/13/2026
Piotroski F-Score
4
/ 9
Borderline
1-Year Forecast
9.98
Transformational upside
Relative Strength
28
/ 100
Underperforming
Debt / Equity
0.00
Debt-free
ROE
-723
Deeply negative
Dividend Yield
0.00%
No dividend
Business Description
Actuate Therapeutics is a Fort Worth, Texas-based company focused on developing new cancer treatments. Its main drug, elraglusib, is currently being tested in clinical trials for several serious conditions, including advanced pancreatic cancer and hard-to-treat cancers in children such as Ewing sarcoma, neuroblastoma, and leukemia. The company was founded in 2015 and was previously known as Apotheca Therapeutics.
